Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis. (Q51872814)

15 April 2018

title

Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis. (English)

1 reference

15 April 2018

main subject

toll-like receptor

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author

Belen Fernandez-Garcia

object named as

Belen Fernandez-Garcia

8

0 references

Noemí Eiró

object named as

Noemí Eiró

1

0 references

author name string

Antonio Altadill

2

1 reference

15 April 2018

Luis M Juárez

3

1 reference

15 April 2018

Manuel Rodríguez

4

1 reference

15 April 2018

Luis O González

5

1 reference

15 April 2018

Sara Atienza

6

1 reference

15 April 2018

Sandra Bermúdez

7

1 reference

15 April 2018

Manuel F Fresno-Forcelledo

9

1 reference

15 April 2018

Luis Rodrigo

10

1 reference

15 April 2018

Francisco J Vizoso

11

1 reference

15 April 2018

publication date

10 July 2013

1 reference

15 April 2018

published in

Hepatology Research

1 reference

15 April 2018

volume

44

1 reference

15 April 2018

page(s)

769-778

1 reference

15 April 2018

issue

7

1 reference

15 April 2018

Epidemiology of viral hepatitis and hepatocellular carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Overview of the molecular bases of resistance to chemotherapy in liver and gastrointestinal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Toll-like receptors and adaptor molecules in liver disease: update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Tissue-specific mRNA expression profiles of human toll-like receptors and related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Performance status assessment in cancer patients. An inter-observer variability study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Study of matrix metalloproteinases and their inhibitors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Study of the expression of toll-like receptors in different histological types of colorectal polyps and their relationship with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Prediction of metastatic breast cancer in non-sentinel lymph nodes based on metalloprotease-1 expression by the sentinel lymph node.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Comparative analysis of the expression of metalloproteases and their inhibitors in resected crohn's disease and complicated diverticular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Toll-like receptors as targets in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

TLR3 and TLR4 expression in healthy and diseased human endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Toll-like receptors and their role in gastrointestinal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

Recent advances in understanding viral evasion of type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12180

21 January 2018

Identifiers

DOI

10.1111/HEPR.12180

1 reference

15 April 2018

PubMed ID

23742263

1 reference

15 April 2018